Recurrent lymphangioleiomyomatosis in a lung allograft with COVID-19: autopsy case report and literature review
Abstract Lymphangioleiomyomatosis (LAM) is a rare neoplastic disease of the lung with a characteristic feature of diffuse cystic changes in bilateral lungs. Lung transplantation is considered to be one of the effective treatments in end stage disease. Patients with LAM who underwent lung transplant...
Main Authors: | Sakda Sathirareuangchai, Jenny L. Weon, Suzanne Tintle, Kiran Batra, Shirley X. Yan, Jose R. Torrealba |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-08-01
|
Series: | Surgical and Experimental Pathology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s42047-021-00095-2 |
Similar Items
-
Computer grading of lung disease severity in patients with lymphangioleiomyomatosis referred for transplantation
by: Angelo M. Taveira-DaSilva, et al.
Published: (2022-09-01) -
Lymphangioleiomyomatosis in a 43-year-old female Nigerian: Diagnosis and Management
by: Oluwafemi Ojo
Published: (2022-06-01) -
Morphology of lungs in pulmonary lymphangioleiomyomatosis – A unique case of bilateral lungs and heart transplant
by: Shirish Sahebrao Chandanwale, et al.
Published: (2023-01-01) -
Effects of sirolimus on Lung function in patients with Lymphangioleiomyomatosis
by: Fatemeh Aghaeimeybodi, et al.
Published: (2019-01-01) -
A Retrospective Study of Lung Transplantation in Patients With Lymphangioleiomyomatosis: Challenges and Outcomes
by: Ji Zhang, et al.
Published: (2021-02-01)